Statistics found where the type is table and where the category is Drug-related infectious diseases (INF)

Category	Title	Type
INF	Table INF-0. Bibliographic references	table
INF	Table INF-1. Prevalence of HIV infection among injecting drug users in the EU, 2008 or most recent year available — Summary table by country.	table
INF	Table INF-2. Prevalence of HCV antibody among injecting drug users in the EU, 2008 or most recent year available — Summary table by country.	table
INF	Table INF-3. Prevalence of markers for HBV infection among injecting drug users in the EU, 2008 or most recent year available — Summary table by country	table
INF	Table INF-104. HIV infections newly diagnosed and AIDS incidence among injecting drug users, by country and year of diagnosis Part (i) (a) cases per million population, (b) number of cases and (c) population sizes, 1993 to 2008	table
INF	Table INF-104. HIV infections newly diagnosed and AIDS incidence among injecting drug users, by country and year of diagnosis Part (ii) (a) AIDS incidence cases per million population, (b) number of cases and (c) population sizes, 1998 to 2008	table
INF	Table INF-105. Notified cases of hepatitis C infection among injecting drug users in the EU: a) Total number of cases where transmission route known, b) number of IDU cases, and c) percentage of IDUs amongst all cases with known risk factor	table
INF	Table INF-106. Notified cases of hepatitis B infection among injecting drug users in the EU: a) Total number of cases where transmission route known, b) number of IDU cases, and c) percentage of IDUs amongst all cases with known risk factor	table
INF	Table INF-107. Incidence studies of hepatitis C virus infection among injecting drug users in the EU	table
INF	Table INF-108. Prevalence of HIV infection among injecting drug users (%), 1991 to 2008	table
INF	Table INF-109. Prevalence of HIV infection among injecting drug users under age 25 (%), 1991 to 2008	table
INF	Table INF-110. Prevalence of HIV infection among new (injecting less than 2 years) injecting drug users (%), 1991 to 2008	table
INF	Table INF-111. Prevalence of hepatitis C infection among injecting drug users (%), 1991 to 2008	table
INF	Table INF-112. Prevalence of hepatitis C infection among injecting drug users under age 25 (%), 1991 to 2008	table
INF	Table INF-113. Prevalence of hepatitis C infection among new (injecting less than 2 years) injecting drug users (%), 1991 to 2008	table
INF	Table INF-114. Prevalence of current hepatitis B infection among injecting drug users (% with HBsAg), 1991 to 2008	table
INF	Table INF-115. Prevalence of antibodies against hepatitis B virus among injecting drug users (%), 1991 to 2008	table
INF	Table INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2008 Part (i) Prevalence of HIV infection (percentage) among injecting drug users in prison	table
INF	Table INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2008 Part (ii) Prevalence of hepatitis C infection (percentage) among injecting drug users in prison	table
INF	Table INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2008 Part (iii) Prevalence of current hepatitis B infection (percentage with HBsAg) among injecting drug users in prison	table
INF	Table INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2008 Part (iv) Prevalence of antibodies against hepatitis B virus (percentage) among injecting drug users in prison	table